Actionable insights straight to your inbox

logo_equities.svg

IPO Report: Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN) is a specialty pharmaceutical company focused on the development and commercialization of novel, long-acting, injectable pain therapies. FLXN is In Phase 2
  • 6 MIN READ

8 IPOs Planned for the Week of February 10

The full IPO calendar is available at IPOpremium.com Ranked by size of IPO, largest first. (1)  Based in Troy, MI, Talmer Bancorp (TLMR) scheduled a $210 million IPO on the Nasdaq with a
  • 2 MIN READ
logo_equities_white

Sign up For our Newsletter

SITEMAP

Contact

© 2022 Equities News | Equities.com, Inc.